The American Society of Transplantation (AST) has developed a survey to address unmet needs with immunosuppression medications for transplant recipients. The survey focuses on transplant recipients' experiences with anti-rejection medications and aims to improve patient-reported outcomes, including health-related quality of life and side effects.
Participation in this survey will make a difference in improving the post-transplant experience for patients. By gathering valuable insights, we aim to advocate for safer outcomes and encourage investment in therapeutics that address the overall well-being of transplant recipients.
We believe in finding solutions that minimize the challenges and side effects of long-term immunosuppression while also promoting treatment adherence and improving transplant survival rates. Your input will help us understand if there are better ways to measure the effectiveness of these treatments in clinical trials.
What Can I Do?
Transplant recipients:
Your voice matters! Join us in shaping the future of transplant care by taking part in this survey. Together, we can make a positive impact on the lives of transplant patients.
Transplant Clinicians and Professionals:
Encourage your patients to complete the survey and make their voices heard on this important issue.